In Nov., a new achievement was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO). A listed biotech company, which was assisted by VCRO, was granted a IND clinical-go for a multinational, Phase III study from the TFDA. The professional, integrated, and local team of VCRO successfully helped customers to achieve the next step of product commercialization.
